Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial

BACKGROUND AND OBJECTIVES: Large, randomized, controlled trials targeting higher hemoglobin level with erythropoiesis-stimulating agents for Western patients with CKD showed harm. However, the effect of anemia correction using erythropoiesis-stimulating agents may differ between CKD subpopulations....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Hayashi, Terumasa, Maruyama, Shoichi, Nangaku, Masaomi, Narita, Ichiei, Hirakata, Hideki, Tanabe, Kenichiro, Morita, Satoshi, Tsubakihara, Yoshiharu, Imai, Enyu, Akizawa, Tadao
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269223/
https://ncbi.nlm.nih.gov/pubmed/32245781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08900719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados